These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20817610)

  • 1. Leukocytapheresis in the treatment of inflammatory bowel disease: Current position and perspectives.
    Vernia P; D'Ovidio V; Meo D
    Transfus Apher Sci; 2010 Oct; 43(2):227-9. PubMed ID: 20817610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective leukocyte apheresis for the treatment of inflammatory bowel disease.
    Abreu MT; Plevy S; Sands BE; Weinstein R
    J Clin Gastroenterol; 2007; 41(10):874-88. PubMed ID: 18090155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adacolumn for selective leukocytapheresis as a non-pharmacological treatment for patients with disorders of the immune system: an adjunct or an alternative to drug therapy?
    Saniabadi AR; Hanai H; Suzuki Y; Ohmori T; Sawada K; Yoshimura N; Saito Y; Takeda Y; Umemura K; Kondo K; Ikeda Y; Fukunaga K; Nakashima M; Beretta A; Bjarnason I; Lofberg R
    J Clin Apher; 2005 Oct; 20(3):171-84. PubMed ID: 15892107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.
    Ljung T; Thomsen OØ; Vatn M; Karlén P; Karlsen LN; Tysk C; Nilsson SU; Kilander A; Gillberg R; Grip O; Lindgren S; Befrits R; Löfberg R
    Scand J Gastroenterol; 2007 Feb; 42(2):221-7. PubMed ID: 17327942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
    Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
    Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action.
    Mitsuyama K; Sata M
    Cytotherapy; 2009; 11(2):229-37. PubMed ID: 19241197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Granulocyte-monocyte apheresis for the treatment of inflammatory bowel disease].
    ; Passalacqua S; Ferraro PM
    G Ital Nefrol; 2012; 29 Suppl 54():S61-3. PubMed ID: 22388832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocytapheresis for the treatment of IBD.
    Sigurbjörnsson FT; Bjarnason I
    Nat Clin Pract Gastroenterol Hepatol; 2008 Sep; 5(9):509-16. PubMed ID: 18665138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Apheresis in inflammatory bowel disease. A valid option?].
    Cabriada JL
    Gastroenterol Hepatol; 2012 Jan; 35(1):22-31. PubMed ID: 22169354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Italian Registry of Therapeutic Apheresis: granulocyte-monocyte apheresis in the treatment of inflammatory bowel disease. A multicentric study.
    Passalacqua S; Ferraro PM; Bresci G; D'Ovidio V; Astegiano M; Principi M; Testa R; D'Incà R; Valpiani D; Armuzzi A; Sablich R; Cavallaro F; Costa F; Di Leo V; Colombo E; Santini A; Aratari A; Lecis P; Saladino V; Riegler G; Marco M; Calella F; Ricci C; Guidi ML; Repaci G; Silla M
    J Clin Apher; 2011 Dec; 26(6):332-7. PubMed ID: 22072543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease.
    Sawada K
    Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S66-77. PubMed ID: 14530661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apheresis in inflammatory bowel disease].
    Nos P; Domènech E
    Gastroenterol Hepatol; 2009; 32(7):509-18. PubMed ID: 19608298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytapheresis in inflammatory bowel diseases: current evidence and perspectives.
    Danese S; Angelucci E; Stefanelli T; Omodei P; Luigiano C; Finazzi S; Pagano N; Repici A; Vecchi M; Malesci A
    Digestion; 2008; 77(2):96-107. PubMed ID: 18382085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic leukocytapheresis for inflammatory bowel disease.
    Saniabadi AR; Hanai H; Fukunaga K; Sawada K; Shima C; Bjarnason I; Lofberg R
    Transfus Apher Sci; 2007 Oct; 37(2):191-200. PubMed ID: 17974479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
    Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent understanding of leukocytapheresis (LCAP) for the treatment of inflammatory bowel disease.
    Mitsuyama K; Yamasaki H; Kuwaki K; Takedatsu H; Sata M
    Curr Pharm Des; 2009; 15(18):2110-9. PubMed ID: 19519448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.